Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound chamomile + lidocaine gel for prevention of laryngeal mask airway-related complications
ChiCTR2300067730Phase 4Recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Nov 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of chamomile + lidocaine (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Incidence of postoperative sore throat. Started Nov 2022; status: recruiting.
02
Drugs
chamomile + lidocaine
Beyond the preview
Go deeper on ChiCTR2300067730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067730.